. Boehringer will partner with LupinGlobal on KRAStargeting combination Cancer therapies in a potentially $700M collaboration httpow.lyBmWg50vWudMÂpic.twitter.comVEAEM9ZwwD
. @Boehringer will partner with @LupinGlobal on KRAS-targeting combination #Cancer therapies in a potentially $700M+ collaboration: http://ow.ly/BmWg50vWudM pic.twitter.com/VEAEM9ZwwD
More From BioPortfolio on ". @Boehringer will partner with @LupinGlobal on KRAS-targeting combination #Cancer therapies in a potentially $700M+ collaboration: http://ow.ly/BmWg50vWudM pic.twitter.com/VEAEM9ZwwD"